Whether hepatitis B minor triple yang can be directly antiviral needs to be decided in the light of the specific condition. For those who are in active hepatitis B minor triyang, or even have liver abnormalities such as liver fibrosis, cirrhosis, liver cancer, etc., usually with positive viral quantification, antiviral treatment is needed to control the development of the disease. For patients with no abnormal liver function, normal quantification of hepatitis B DNA and normal morphology of the liver, direct antiviral treatment is not recommended for the time being. The main reason is that the current antiviral drugs can only control the replication of the hepatitis B virus, but have not reached the degree of complete elimination of the hepatitis B virus, and can only control the amount of the virus, so as to achieve the role of preventing the virus from causing further damage to the liver cells. Hepatitis B minor triple positive, need to actively listen to the doctor’s advice for examination and treatment.